Josep Cabau-Rodes
Elite in Transcatheter Aortic Valve Replacement (TAVR)

Josep Cabau-Rodes

St. Paul's Hospital, 
Vancouver, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Elite in Transcatheter Aortic Valve Replacement (TAVR)
St. Paul's Hospital, 
Vancouver, CA 
OverviewLocationsClinical Research

Overview

Josep Cabau-Rodes practices in Vancouver, Canada. Mr. Cabau-Rodes is rated as an Elite expert by MediFind in Transcatheter Aortic Valve Replacement (TAVR). His top areas of expertise are Aortic Valve Stenosis, Aortic Regurgitation, Heart Block, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

His clinical research consists of co-authoring 729 peer reviewed articles and participating in 14 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 386 articles and participated in 4 clinical trials in the study of Transcatheter Aortic Valve Replacement (TAVR).

Gender
Male

Locations

St. Paul's Hospital, Vancouver, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

14 Clinical Trials

A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Tricuspid Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System and Optimal Medical Therapy (OMT) Compared to OMT Alone in Patients With Tricuspid Regurgitation
A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Tricuspid Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System and Optimal Medical Therapy (OMT) Compared to OMT Alone in Patients With Tricuspid Regurgitation
Enrollment Status: Recruiting
Publish Date: September 22, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
A Phase IIb, Randomized, Double-blind, Placebo Controlled Study Using Transplantation of Autologous Early Endothelial Progenitor Cells(EPCs) for Patients Who Have Suffered Acute Myocardial Infarction
A Phase IIb, Randomized, Double-blind, Placebo Controlled Study Using Transplantation of Autologous Early Endothelial Progenitor Cells(EPCs) for Patients Who Have Suffered Acute Myocardial Infarction
Enrollment Status: Active_not_recruiting
Publish Date: August 15, 2025
Intervention Type: Biological
Study Drugs: Plasma-Lyte A and Autologous Plasma, Autologous EPCs, Autologous EPCs Transfected with human eNOS
Study Phase: Phase 2
Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy After Replacement of Tricuspid Valve With Transcatheter Device
Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy After Replacement of Tricuspid Valve With Transcatheter Device
Enrollment Status: Active_not_recruiting
Publish Date: August 15, 2025
Intervention Type: Device
Study Phase: Not Applicable
ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects InDicatEd for TAVR
ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects InDicatEd for TAVR
Enrollment Status: Active_not_recruiting
Publish Date: August 07, 2025
Intervention Type: Device
Study Phase: Not Applicable
Optimize PRO Transcatheter Aortic Valve Replacement Post Market Study
Optimize PRO Transcatheter Aortic Valve Replacement Post Market Study
Enrollment Status: Completed
Publish Date: July 28, 2025
Intervention Type: Device
Characterization of Radiolabeled Tracer Uptake Pattern in Noninfected Transcatheter Aortic Valves. The COUNT Study. A Prospective, Observational Study.
Characterization of Radiolabeled Tracer Uptake Pattern in Noninfected Transcatheter Aortic Valves. The COUNT Study. A Prospective, Observational Study.
Enrollment Status: Active_not_recruiting
Publish Date: May 30, 2024
Intervention Type: Radiation
Medtronic Evolut™ EXPAND TAVR I Feasibility Study
Medtronic Evolut™ EXPAND TAVR I Feasibility Study
Enrollment Status: Terminated
Publish Date: January 10, 2024
Intervention Type: Device
Study Phase: Not Applicable
Transcatheter Aortic Valve Replacement Versu Surgical Aortix Valve Replacement for Treating Elderly Patients With Severe Aortic Stenosis and Small Aortic Annuli: A Prospective Randomized Study The VIVA Trial
Transcatheter Aortic Valve Replacement Versu Surgical Aortix Valve Replacement for Treating Elderly Patients With Severe Aortic Stenosis and Small Aortic Annuli: A Prospective Randomized Study The VIVA Trial
Enrollment Status: Active_not_recruiting
Publish Date: December 20, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
Comparison of the Balloon-Expandable Edwards Valve and Self-Expandable CoreValve Evolut R or Evolut PRO System for the Treatment of Small, Severely Dysfunctional Surgical Aortic Bioprotheses: A Pilot Prospective Randomized Trial. The 'LYTEN' Trial
Comparison of the Balloon-Expandable Edwards Valve and Self-Expandable CoreValve Evolut R or Evolut PRO System for the Treatment of Small, Severely Dysfunctional Surgical Aortic Bioprotheses: A Pilot Prospective Randomized Trial. The 'LYTEN' Trial
Enrollment Status: Active_not_recruiting
Publish Date: December 20, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
Assessment of Arrhythmic BuRdEn With Post-ProCedural COntinuous ElectRocarDiographic Monitoring in Patients Undergoing Transcatheter Aortic Valve Implantation: The RECORD Study
Assessment of Arrhythmic BuRdEn With Post-ProCedural COntinuous ElectRocarDiographic Monitoring in Patients Undergoing Transcatheter Aortic Valve Implantation: The RECORD Study
Enrollment Status: Active_not_recruiting
Publish Date: December 20, 2023
Intervention Type: Device
Study Phase: Not Applicable
AltaValve Early Feasibility Study Protocol
AltaValve Early Feasibility Study Protocol
Enrollment Status: Unknown
Publish Date: September 01, 2023
Intervention Type: Device
Study Phase: Not Applicable
The SAVVY Guidewire in Transcatheter Aortic Valve Replacement Procedures: A Feasibility Study
The SAVVY Guidewire in Transcatheter Aortic Valve Replacement Procedures: A Feasibility Study
Enrollment Status: Completed
Publish Date: January 18, 2022
Intervention Type: Device
Study Phase: Not Applicable
Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve CE Mark Trial
Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve CE Mark Trial
Enrollment Status: Terminated
Publish Date: May 19, 2020
Intervention Type: Device
Study Phase: Not Applicable
Clinical Investigation of the Caisson Transcatheter Mitral Valve Replacement (TMVR) System for Percutaneous Mitral Valve Replacement in Patients With Symptomatic Mitral Regurgitation
Clinical Investigation of the Caisson Transcatheter Mitral Valve Replacement (TMVR) System for Percutaneous Mitral Valve Replacement in Patients With Symptomatic Mitral Regurgitation
Enrollment Status: Unknown
Publish Date: January 28, 2020
Intervention Type: Device
Study Phase: Not Applicable
View 13 Less Clinical Trials

715 Total Publications

New York Valves: The Structural Heart Summit (June 25-27, 2025).
New York Valves: The Structural Heart Summit (June 25-27, 2025).
Journal: Structural heart : the journal of the Heart Team
Published: July 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cabau-Rodes's expertise for a condition
ConditionClose
View All 9 Elite Conditions
View All 8 Advanced Conditions
View All 38 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile